for structured treatment, and to reduce drug or alcohol related harm (as appropriate).
QRP 6: Improving engagement with structured drug treatment
Access to structured drug treatment should be within national waiting times for drug treatment and those accessing structured drug treatment should usually be retained for at least 12 weeks.
QRP 7: Structured treatment delivery: A care planning approach to deliver positive change in clients’ lives
All individuals in structured drug treatment have an identifiable written care plan, which tracks their progress and is regularly reviewed. Clients in drug treatment should show measurable positive change while in drug treatment across a range of domains. This should include: less illegal drug misuse; better health; less risk of infection and transmission of BBVs, reduced risk of behaviours associated with overdose; fewer drug-related offences committed; better social functioning and evidence of reintegration into the community.
QRP 8: Improving reintegration and treatment completion Service users who need to remain in structured treatment are retained while achieving improvements in their health and social functioning. Service users who can progress out of drug treatment are supported to complete treatment via a planned exit with aftercare support. Drug services have defined pathways to enable service users to integrate into the community during and following the completion of treatment, including access to appropriate housing, education, employment and mainstream health.
QRP 9: Provision of aftercare and reintegration All those that have left structured drug treatment should have access to drug-related support and mutual aid groups. This should include easy access back to structured drug treatment in the case of relapse.
Models of care for treatment of adult drug misusers: Update 2006